Recherche
-
Will the future of pharmacovigilance be more automated?
(Expert Opinion on Drug Safety. vol. 22, n° 7, pp. 541-548, 2023-07-01)Article de revue -
Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysis.
(Frontiers in Pharmacology. vol. 14, pp. 1129244, 2023-05-15)Article de revueLibre accès -
Invasive fungal infection incidence and risk factors in patients receiving ibrutinib in real-life settings: A nationwide population-based cohort study
(Mycoses, 2023-11-20)Article de revue -
Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study
(Drug Safety. vol. 46, n° 9, pp. 857-866, 2023-09-01)Article de revueLibre accès -
Statin treatment is not associated with an increased risk of adrenal insufficiency in real-world setting
(Frontiers in Endocrinology. vol. 14, pp. 1254221, 2023-09-25)Article de revueLibre accès -
Bleeding risk with concurrent use of anticoagulants and ibrutinib: A population-based nested case-control study
(British Journal of Haematology. vol. 203, n° 2, pp. 311-318, 2023-10-01)Article de revue